Search Results - "Noguchi, Masanori"

Next‐generation peptide vaccines for advanced cancer by Yamada, Akira, Sasada, Tetsuro, Noguchi, Masanori, Itoh, Kyogo

“…Many clinical trials of peptide vaccines have been carried out since the first clinical trial of a melanoma antigen gene‐1‐derived peptide‐based vaccine was…”
Get full text

Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine by Noguchi, Masanori, Sasada, Tetsuro, Itoh, Kyogo

“…Since both tumor cells and host immune cell repertoires are diverse and heterogeneous, immune responses against tumor-associated antigens should differ…”
Get full text

Personalized peptide vaccine for treatment of advanced cancer by Sasada, Tetsuro, Yamada, Akira, Noguchi, Masanori, Itoh, Kyogo

“…The field of cancer immunotherapy has moved forward drastically in the past 20 years, since many tumor-associated antigens (TAA) have been identified. Although…”
Get more information

Personalized peptide vaccination as second‐line treatment for metastatic upper tract urothelial carcinoma by Suekane, Shigetaka, Ueda, Kousuke, Nishihara, Kiyoaki, Sasada, Tetsuro, Yamashita, Takuto, Koga, Noriko, Yutani, Shigeru, Shichijo, Shigeki, Itoh, Kyogo, Igawa, Tsukasa, Noguchi, Masanori

“…This study investigated the applicability of personalized peptide vaccination (PPV) for patients with metastatic upper tract urothelial cancer (mUTUC) after…”
Get full text

Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers by Noguchi, Masanori, Koga, Noriko, Moriya, Fukuko, Suekane, Shigetaka, Yutani, Shigeru, Yamada, Akira, Shichijo, Shigeki, Kakuma, Tatuyuki, Itoh, Kyogo

“…Peptide‐based cancer vaccines are able to induce strong immune responses, but their clinical results are unsatisfactory. To determine clinically correlated…”
Get full text

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial by Noguchi, Masanori, Arai, Gaku, Egawa, Shin, Ohyama, Chikara, Naito, Seiji, Matsumoto, Kazumasa, Uemura, Hirotsugu, Nakagawa, Masayuki, Nasu, Yasutomo, Eto, Masatoshi, Suekane, Shigetaka, Sasada, Tetsuro, Shichijo, Shigeki, Yamada, Akira, Kakuma, Tatsuyuki, Itoh, Kyogo

“…A novel cancer vaccine consisting of 20 mixed peptides (KRM-20) was designed to induce cytotoxic T lymphocytes (CTL) against twelve different tumor-associated…”
Get full text

Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line by Ueda, Kosuke, Ogasawara, Sachiko, Akiba, Jun, Nakayama, Masamichi, Todoroki, Keita, Ueda, Keiko, Sanada, Sakiko, Suekane, Shigetaka, Noguchi, Masanori, Matsuoka, Kei, Yano, Hirohisa

“…Cancer stem cells (CSC) or cancer stem cell-like cells (CSC-LCs) have been identified in many malignant tumors. CSCs are proposed to be related with drug…”
Get full text

Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine by Koga, Noriko, Moriya, Fukuko, Waki, Kayoko, Yamada, Akira, Itoh, Kyogo, Noguchi, Masanori

“…This randomized phase II study investigated the immunological efficacy of herbal medicines (HM) using Hochu‐ekki‐to and Keishi‐bukuryo‐gan in combination with…”
Get full text

Clinical development of immunotherapy for prostate cancer by Noguchi, Masanori, Koga, Noriko, Igawa, Tsukasa, Itoh, Kyogo

“…Prostate cancer is the most common cancer in men, and the second leading cause of cancer‐related death in Western countries. Prostate cancer‐related death…”
Get full text

Prospect and progress of personalized peptide vaccinations for advanced cancers by Sakamoto, Shinjiro, Noguchi, Masanori, Yamada, Akira, Itoh, Kyogo, Sasada, Tetsuro

“…The field of cancer immunotherapy has made dramatic progress in the past 20 years, in part due to the identification of numerous tumor-associated antigens…”
Get more information

Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients by Suekane, Shigetaka, Yutani, Shigeru, Yamada, Akira, Sasada, Tetsuro, Matsueda, Satoko, Takamori, Shinzo, Toh, Uhi, Kawano, Kouichiro, Yoshiyama, Koichi, Sakamoto, Shinjiro, Sugawara, Shunichi, Komatsu, Nobukazu, Yamada, Teppei, Naito, Masayasu, Terasaki, Mizuhiko, Mine, Takashi, Itoh, Kyogo, Shichijo, Shigeki, Noguchi, Masanori

“…Peptide‑based cancer vaccines have failed to provide sufficient clinical benefits in order to be approved in clinical trials since the 1990s. To understand the…”
Get full text

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy by Noguchi, Masanori, Moriya, Fukuko, Suekane, Shigetaka, Matsuoka, Kei, Arai, Gaku, Matsueda, Satoko, Sasada, Tetsuro, Yamada, Akira, Itoh, Kyogo

“…BACKGROUND Docetaxel‐based chemotherapy (DBC) showed limited clinical efficacy for castration‐resistant prostate cancer (CRPC) patients. To explore cancer…”
Get full text

Testicular sarcoidosis with bilateral scrotal swelling by Kimura, Shoichi, Momozono, Kosuke, Shimamatsu, Kazuhide, Noguchi, Masanori

“…Introduction Sarcoidosis is a disease in which noncaseating granulomas form in several organs, particularly in the lungs and skin. Male genitourinary…”
Get full text

Personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel chemotherapy: A randomized, double-blind, placebo-controlled, phase III trial by Noguchi, Masanori, Fujimoto, Kiyohide, Arai, Gaku, Uemura, Hiroji, Hashine, Katsuyoshi, Matsumoto, Hiroaki, Fukasawa, Satoshi, Nakatsu, Hideomi, Takenaka, Atsushi, Fujisawa, Masato, Uemura, Hirotsugu, Naito, Seiji, Egawa, Shin, Fujimoto, Hiroyuki, Hinotsu, Shiro, Itoh, Kyogo, Kohjimoto, Yasuo

“…Abstract only 5033 Background: To develop a new treatment modality, we conducted a phase III randomized trial of personalized peptide vaccination (PPV) for…”
Get full text

A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients by YUTANI, SHIGERU, KOMATSU, NOBUKAZU, YOSHITOMI, MUNEHIRO, MATSUEDA, SATOKO, YONEMOTO, KOJI, MINE, TAKASHI, NOGUCHI, MASANORI, ISHIHARA, YUKI, YAMADA, AKIRA, ITOH, KYOGO, SASADA, TETSURO

“…Pancreatic cancer is one of the most aggressive cancers with a median survival time (MST) of <6 months in chemotherapy-resistant patients. Therefore, the…”
Get full text

Identification of novel Lck‐derived T helper epitope long peptides applicable for HLA‐A2+ cancer patients as cancer vaccine by Matsueda, Satoko, Shichijo, Shigeki, Nagata, Sayaka, Seki, Chieko, Yamada, Akira, Noguchi, Masanori, Itoh, Kyogo

“…The present study attempted to identify T helper epitope long peptides capable of inducing cytotoxic T lymphocytes (CTL) from Lck antigen (p56Lck), the src…”
Get full text

Recent Advances in Cancer Vaccines: An Overview by Itoh, Kyogo, Yamada, Akira, Mine, Takashi, Noguchi, Masanori

“…The field of cancer vaccines is currently in an active state of clinical investigations. Human papilloma virus vaccine has been approved as a prophylactic…”
Get full text

Malignant lymphoma of the bladder with bilateral hydronephrosis by Kawaguchi, Yoshihiro, Kimura, Shoichi, Momozono, Kosuke, Igawa, Tsukasa, Noguchi, Masanori

“…Lymphoma of the urinary bladder is uncommon, and upper urinary tract obstruction due to lymphoma is rare. Herein, we report a case of malignant lymphoma of the…”
Get full text

Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination by Komatsu, Nobukazu, Matsueda, Satoko, Tashiro, Kousuke, Ioji, Tetsuya, Shichijo, Shigeki, Noguchi, Masanori, Yamada, Akira, Doi, Atsushi, Suekane, Shigetaka, Moriya, Fukuko, Matsuoka, Kei, Kuhara, Satoru, Itoh, Kyogo, Sasada, Tetsuro

“…BACKGROUND: Because only a subset of patients show clinical responses to peptide‐based cancer vaccination, it is critical to identify biomarkers for selecting…”
Get full text

Female urethral diverticulum containing large calculi by Kimura, Shoichi, Kawaguchi, Yoshihiro, Momozono, Kosuke, Noguchi, Masanori

“…Urinary stones in female urethral diverticulum are rarely seen. We report a 79-year-old woman who presented with irritative lower urinary tract symptoms and…”
Get full text